Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.61 - $0.98 $85,276 - $137,001
-139,797 Reduced 55.55%
111,851 $80,000
Q2 2023

Aug 14, 2023

SELL
$0.92 - $1.48 $90,610 - $145,765
-98,490 Reduced 28.13%
251,648 $244,000
Q4 2022

Feb 10, 2023

BUY
$1.36 - $22.72 $148 - $2,476
109 Added 0.03%
350,138 $521,000
Q3 2022

Nov 14, 2022

BUY
$2.97 - $23.6 $103,629 - $823,451
34,892 Added 11.07%
350,029 $977,000
Q1 2022

May 13, 2022

BUY
$3.42 - $6.37 $67,261 - $125,278
19,667 Added 6.66%
315,137 $1.31 Million
Q4 2021

Feb 14, 2022

SELL
$5.02 - $9.82 $406,685 - $795,547
-81,013 Reduced 21.52%
295,470 $1.48 Million
Q3 2021

Nov 12, 2021

BUY
$3.23 - $24.73 $1 Million - $7.67 Million
310,249 Added 468.41%
376,483 $3.82 Million
Q2 2021

Aug 13, 2021

BUY
$2.72 - $3.8 $180,156 - $251,689
66,234 New
66,234 $226,000

Others Institutions Holding NURO

# of Institutions
1
Shares Held
320
Call Options Held
0
Put Options Held
0

About NeuroMetrix, Inc.


  • Ticker NURO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 7,757,230
  • Market Cap $31.3M
  • Description
  • NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...
More about NURO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.